Información del artículo
El Texto completo está disponible en PDF
Referencias
[1.]
S.A. Al-Mutawa, S.M. Hegab.
Behcet's disease.
Clin Exp Med, 4 (2004), pp. 103-131
[2.]
L.M. Al-Otaibi, S.R. Porter, T.W. Poate.
Behcet's disease: A review.
J Dent Res, 84 (2005), pp. 209-222
[3.]
A. Bonfioli, F. Orefice.
Behcet's disease.
Semin Ophthalmol, 20 (2005), pp. 199-206
[4.]
V. Kaklamani, G. Vaiopoulos, P. Kaklamanis.
Behcet's disease.
Arthritis Rheum, 27 (1998), pp. 197-217
[5.]
J.V. Ghate, J.L. Jorizzo.
Behçet's disease and complex aphthosis.
J Am Acad Dermatol, 40 (1999), pp. 1-18
[6.]
S. Yurdakul, V. Hamuryudan, H. Yazici.
Behcet syndrome.
Curr Opin Rheumatol, 16 (2003), pp. 38-42
[8.]
Hippocrates. Third book on epidemiology. Case 7. Kaktos (ed). 993; 13: 209.
[9.]
J.R. Lisse, M. Oberto-Medina.
Behcet Disease, (2006),
[10.]
Y. Tuzun, S. Yurdakul, M.M. Cem, Y. Ozyazgan, V. Hamuryudan, B. Tuzun, et al.
Epidemiology of Behcet's syndrome in Turkey.
Int J Dermatol, 35 (1996), pp. 618-620
[11.]
L. Jaber, G. Milo, G.J. Halpern, I. Krause, A. Weinberger.
Prevalence of Behcet's disease in an Arab community in Israel.
Ann Rheum Dis, 61 (2002), pp. 365-366
[12.]
Z.S. Al Rawi, A.H. Neda.
Prevalence of Behcet's disease among Iraqis.
Adv Exp Med Biol, 528 (2003), pp. 37-41
[13.]
N. Mizuki, M. Ota, K. Yabuki, Y. Katsuyama, H. Ando, G.D. Palimeris, et al.
Localization of the pathogenic gene of Behcet's disease by microsatellite analysis of three different populations.
Invest Ophthalmol Vis Sci, 41 (2000), pp. 3702-3708
[14.]
C.C. Zouboulis, I. Kotter, D. Djawari, W. Kirch, P.K. Kohl, F.R. Ochsendorf, et al.
Epidemiological features of Adamantiades - Behcet's disease in Germany and in Europe.
Yonsei Med J, 38 (1997), pp. 411-422
[15.]
M.A. Gonzalez-Gay, C. Garcia-Porrua, F. Branas, L. Lopez- Lazaro, I. Olivieri.
Epidemiologic and Clinical aspects of Behcet's disease in a defined area of Northwestern Spain, 1988-1997.
J Rheumatol, 27 (2000), pp. 703-707
[16.]
A. Londoño, D. Hernández, C. Palacios, H. Castaño, C. Montoya, J. Donado, et al.
Enfermedad de Behcet: espectro clínico de ocho pacientes en la ciudad de Medellín.
Rev Col Reumatol, 10 (2003), pp. 199-205
[17.]
C.C. Zouboulis, G. Vaiopoulos, N. Marcomichelakis, G. Palimeris, I. Markidou, B. Thouas, et al.
Onset signs, clinical course, prognosis, treatment and aoutcome of adult patients with Adamantiades-Behcet disease in Greece.
Clin Exp Rheumatol, 21 (2003), pp. S19-S26
[18.]
W.K. Jacyk.
Behçet's disease in South African blacks: report of five cases.
J Am Acad Dermatol, 30 (1994), pp. 869-873
[19.]
A. Gül.
Behcet's disease: An update on the pathogenesis.
Clin Exp Rheumatol, 19 (2001), pp. S6-S12
[20.]
P. Fietta.
Behcet's disease: Familial clustering and immunogenetics.
Clin Exp Rheumatol, 23 (2005), pp. S96-S105
[21.]
A. Gül, M. Inanc, L. Ocal, O. Aral, M. Konice.
Familial aggregation of Behcet's disease in Turkey.
Ann Rheum Dis, 59 (2000), pp. 622-625
[22.]
I. Kóne-Paut, I. Geisler, B. Wechsler, S. Ozen, H. Ozdogan, M. Rozenbaum, et al.
Familial aggregation in Behcet's disease: high frequency in siblings and parents of pediatric probando.
J Pediatr, 135 (1999), pp. 89-93
[23.]
J.A. Birdstewart.
Genetic analysis of families of patients with Behcet's syndrome: data incompatible with autosomal recessive inheritance.
Ann Rheum Dis, 45 (1986), pp. 265-268
[24.]
I. Fresko, M. Soy, V. Hamuryudan, S. Yurdakul, S. Yavuz, Z. Tümer, et al.
Genetic anticipation in Behcet's syndrome.
Ann Rheum Dis, 57 (1998), pp. 45-48
[25.]
N.W. Zwirner, K. Dole, P. Stastny.
Differential surface expresión of MICA by endotelial cells, fibroblast, keratinocytes, and monocytes.
Hum Immunol, 60 (1999), pp. 323-330
[26.]
M. Ota, N. Mizuki, Katsuyamay, G. Tamiya, T. Shiina, A. Oka, et al.
The critical region for Behcet's disease in the human major histocompatibility complex is reduced to 46-kb segment centromeric of HLA – B, by association analysis using refined microsatellite mapping.
Am J Hum Genet, 64 (1999), pp. 1406-1410
[27.]
N. Misuki, M. Ota, Y. Katsuyama, K. Yabuki, H. Ando, K. Goto, et al.
Association analysis between the MIC-A and HLA - B alleles in Japanese patients with Behcet's disease.
Arthritis Rheum, 42 (1999), pp. 1961-1966
[28.]
G.R. Wallace, D.H. Verita, L.J. Delamaine, S. Ohno, H. Inoko, M. Ota, et al.
MIC- A allele profiles and HLA class I associations in Behcet's disease.
Immunogenetics, 49 (1999), pp. 613-617
[29.]
K. Sano, K. Yabuki, Y. Imagawa, T. Shiina, N. Mizuki, S. Ohno, et al.
The absence of disease-specific polymorphisms within the HLA-B51 gene that is the susceptible locus for Behcet's disease.
Tissue Antigens, 58 (2001), pp. 77-82
[30.]
A. Gül, A.H. Hajeer, J. Worthington, J.H. Barret, W.E. Ollier, A.J. Silman.
Evidence for linkage of the HLA-B locus in Behcet's disease, obtained using the transmisión disequilibrium test.
Arthritis Rheum, 44 (2001), pp. 239-241
[31.]
S. Hegab, S. Al Mutawa.
Immunopathogenesis of Behcet's disease.
Clinical Immunol, 96 (2000), pp. 174-186
[32.]
S. Lee, D. Bang, Y.H. Cho, E.S. Lee, S. Sohn.
Polymerase chain reaction reveals herpes simplex virus DNA of patients with Behcet's disease.
Arch Dermatol Res, 288 (1996), pp. 179-183
[33.]
S. Sohn, E.S. Lee, D. Bang, Lee S.
Behcet's disease-like symptoms induced by Herpes simplex virus in ICR mice.
Eur J Dermatol, 8 (1998), pp. 21-23
[34.]
E.B. Baskan, E. Yilmaz, H. Saricaoglu, G. Alkan, I. Ercan, R. Mistik.
Detection of parvovirus B19 DNA in the lesional skin of patients with Behcet's disease.
Clin Exp Dermatol, 32 (2007), pp. 186-190
[35.]
C. Cooper, E.C. Pippard, H. Sharp, C. Wickham, M.A. Chamberlain, D.J. Barker.
Is Behcet's disease triggered by childhood infection.
Ann Rheum Dis, 48 (1989), pp. 421-423
[36.]
S. Narikawa, Y. Suzuki, M. Takahashi, A. Furukawa, T. Sakane, Y. Mizushima.
Streptococcus oralis previously identified as uncommon Streptococcus sanguis in Behcet's disease.
Arch Oral Biol, 40 (1995), pp. 685-690
[37.]
H. Direskeneli, G. Saruhan-Direskeneli.
The role of heat shock proteins in Behcet's disease.
Clin Exp Rheumatol, 21 (2003), pp. S44-S48
[38.]
L. Emmi, E. Brugnolo, G. Salvati, T. Marchione.
Immunopathological aspects of Behcet's disease.
Clin Exp Rheumatol, 13 (1995), pp. 687-691
[39.]
A. Al-Dalaan, S. Al-Sedairy, S. Al-Balaa, M. Al-Janadi, K. Elramahi, S. Bahabri, et al.
Enhanced interleukin 8 secretion in circulation of patients with Behcet's disease.
J Rheumatol, 22 (1995), pp. 904-907
[40.]
B. Turan, H. Gallati, H. Erdi, A. Gurler, B.A. Michel, P.M. Villiger.
Systemic levels of the T cell regulatory cytokines IL- 10 and IL-12 in Behcet's disease: soluble TNFR-75 as a biological marker of disease activity.
J Rheumatol, 24 (1997), pp. 128-132
[41.]
N. Yamashita, H. Kaneoka, S. Kaneko, M. Takeno, K. Oneda, H. Koizumi, et al.
Role of gamma delta T lymphocytes in the development of Behcet's disease.
Clin Exp Immunol, 107 (1997), pp. 241-247
[42.]
S. Sahin, R. Lawrence, H. Direskeneli, V. Hamuryudan, H. Yazici, T. Akoglu.
Monocyte activity in Behcet's disease.
Br J Rheumatol, 35 (1996), pp. 424-429
[43.]
I.C. Haznedaroglu, O.I. Ozcebe, O. Ozdemir, I. Celik, S.V. Dundar, S. Kirazli.
Impaired haemostatic kinetics and endothelial function in Behcet's disease.
J Intern Med, 240 (1996), pp. 181-187
[44.]
A. Gül, U. Özbek, C. Öztürk, M. Inanc, M. Konice, T. Özcelik.
Coagulation factor V gene mutation increases the risk of venous thrombosis in Behcet's disease.
Br J Rheumatol, 35 (1996), pp. 1178-1180
[45.]
A. Gül, A.B. Aslantas, T. Tekinay, M. Konice, T. Özcelik.
Procoagulant mutations and venous thrombosis in Behcet's disease.
Rheumatology, 38 (1999), pp. 1298-1299
[46.]
R. Mader, M. Ziv, M. Adawi, R. Mader, I. Lavi.
Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behcet's disease.
J Rheumatol, 26 (1999), pp. 2404-2408
[47.]
E. Alpsoy, L. Donmez, M. Onder, S. Gunasti, A. Usta, Y. Karincaoglu, et al.
Clinical features and natural course of Behcet's disease in 661 cases: a multicentre study.
Br J Dermatol, 157 (2007), pp. 901-906
[48.]
U. Tursen, A. Gürler, A. Boyvat.
Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet's disease.
Int J Dermatol, 42 (2003), pp. 346-351
[49.]
D.M. Main, M.A. Chamberlain.
Clinical differentiation of oral ulceration in Behcet's disease.
Br J Rheumatol, 31 (1992), pp. 767-770
[50.]
The International Study Group for Behcet's Disease..
Evaluation of diagnostic (classification) criteria in Behcet's disease - towards internationally agreed criteria.
Br J Rheumatol, 31 (1992), pp. 299-308
[51.]
I. Krause, L. Leibovici, D. Guedj, Y. Molad, Y. Uziel, A. Weinberger.
Disease patterns of patients with Behcet's disease demonstrated by factor analysis.
Clin Exp Rheumatol, 17 (1999), pp. 347-350
[52.]
C.M. Magro, A.N. Crowson.
Cutaneous manifestations of Behcet's disease.
Int J Dermatol, 34 (1995), pp. 159-165
[53.]
R. King, A.N. Crowson, E. Murray, C.M. Magro.
Acral purpuric papulonodular lesions as a manifestation of Behcet's disease.
Int J Dermatol, 34 (1995), pp. 190-192
[54.]
O. Oguz, S. Serdaroglu, Y. Turzun, N. Erdogan, H. Yazici, H. Savaskan.
Acute febrile neutrophilic dermatosis (Sweet's syndrome) associated with Behcet's disease.
Int J Dermatol, 31 (1992), pp. 645-646
[55.]
U. Takeda, K. Kureda, H. Shinkai.
Encapsulated necrosis associated with Behcet's disease.
J Dermatol, 26 (1999), pp. 522-526
[56.]
H.S. Inaloz, C. Evereklioglu, B. Unal, N. Kirtak, A. Eralp, S.S. Inaloz.
The significance of immunohistochemistry in the skin pathergy reaction of patients with Behçet's syndrome.
JEADV, 18 (2004), pp. 56-61
[57.]
N. Dilsen, M. Konice, O. Aral, L. Ocal, M. Inanc, A. Gul.
Comparative study of the skin pathergy test with blunt and sharp needles in Behcet's disease: confirmed specificity but decreased sensitivity with sharp needles.
Ann Rheum Dis, 52 (1993), pp. 823-825
[58.]
F. Davatchi, F. Shahram, A. Nadji, A.R. Jamshidi, C. Chams, H. Chams, et al.
Influence of pathergy test on the accuracy of different diagnosis criteria for Behçet's disease.
Adv Exp Med Biol, 528 (2003), pp. 109-112
[59.]
I. Tunal-Tutkun, S. Onal, R. Altan-Yaycioglu, H. Huseyin.
Urgancioglu. Uveitis in Behcet disease: an analysis of 880 Patients.
Am J Ophthalmol, 138 (2004), pp. 373-380
[60.]
A. Okada.
Behcet's disease: general concepts and recent advances.
Curr Opin Ophthalmol, 17 (2006), pp. 551-556
[61.]
D. Ben-Ezra, E. Cohen.
Treatment and visual prognosis in Behcet's disease.
Br J Ophthalmol, 70 (1986), pp. 589-592
[62.]
M. Sakamoto, K. Akasawa, Y. Nishioka, H. Sanui, H. Inomata, Y. Nose.
Prognostic factors of vision in patients with Behcet's disease.
Opthalmology, 102 (1995), pp. 317-321
[63.]
J.T. Lie.
Vascular involvement in Behcet's disease; arterial and venous and vessels of all sizes.
J Rheumatol, 19 (1992), pp. 341-342
[64.]
U. Alpagut, M. Ugurlucan, E. Dayioglu.
Major arterial involvement and review of Behcet's disease.
Ann Vasc Surg, 21 (2007), pp. 232-239
[65.]
M. Hamza.
Large artery involvement in Behcet's disease.
J Rheumatol, 14 (1987), pp. 554-559
[66.]
M. Benekli, I.H. Gullu, J.C. Haznedaroglu.
Ischemic heart disease in Behcet's syndrome.
Rheumatol Int, 17 (1998), pp. 251
[67.]
A.B. Haghighi, R. Pourmand, A. Nikseresht.
Neuro-Behcet disease: a review.
Neurologist, 11 (2005), pp. 80-89
[68.]
G. Akman - Demir, P. Serdaroglu, B. Tasci, the Neuro-Behcet study group.
Brain, 122 (1999), pp. 2171-2181
[69.]
E. Diri, C. Mat, V. Hamuryudan, S. Yurdakul, N. Hýzlý, N. Yazýcý.
Papulopustular skin lesions are seen more frequently in patients with Behcet's syndrome who have arthritis: a controlled and masked study.
Ann Rheum Dis, 60 (2001), pp. 1074-1076
[70.]
S. Yardakul, H. Yazici, Y. Tuzun, H. Pazarli, B. Yalcin, M. Altac, et al.
The arthritis of Behcet's disease: A prospective study.
Ann Rheum Dis, 42 (1983), pp. 505-515
[71.]
H. Yazici, I. Fresko, S. Yurdakul.
Behçet's syndrome: disease manifestations, management, and advances in treatment.
Nat Clin Pract Rheumatol, 3 (2007), pp. 148-155
[72.]
F. Erkan, E. Kiyan, A. Tunaci.
Pulmonary complications of Behcet's disease.
Clin Chest Med, 23 (2002), pp. 493-503
[73.]
Y. Bayraktar, F. Balkanci, M. Bayraktar, M. Calguneri.
Budd-Chiari syndrome: a common complication of Behcet's disease.
Am J Gastroenterol, 92 (1997), pp. 858-862
[74.]
A.S. Rugby, M.A. Chamberlain, B. Bhakta.
Classification and assessment of rheumatic diseases: Part 1. Behcet's disease.
Baillieres Clin Rheumatol, 9 (1995), pp. 375-395
[75.]
S.I. Chun, W.P. Su, S. Lee.
Histopathologic study of cutaneous lesions in Behcet's syndrome.
J Dermatol, 17 (1990), pp. 333-341
[76.]
J.L. Jorizzo.
Behcet's disease: an update based on the 1985 conference in London.
Arch Dermatol, 122 (1986), pp. 556-558
[77.]
Behcet's disease. In: Mckee PH, Calonje E, Granter SR. Pathology of the skin with clinical correlations. 3 Ed. Elsevier Mosby. 2005 p. 685-689.
[78.]
K. Chen, Y. Kawahara, S. Miyakawa, T. Nishikawa.
Cutaneous vasculitis in Behcet's disease: a clinical and histopathologic study of 20 patients.
J Am Acad Dermatol, 36 (1997), pp. 689-696
[79.]
G. Lawton, B.B. Bhakta, M.A. Chamberlain, A. Tennant.
The Behçet's Disease Activity Index.
Rheumatology, 43 (2004), pp. 73-78
[80.]
B.B. Bhakta, P. Brennan, T.E. James, M.A. Chamberlain, B.A. Noble, A.J. Silman.
Behcet's disease: evaluation of a new instrument to measure clinical activity.
Rheumatology, 38 (1999), pp. 728-733
[81.]
H. Yacizi, Y. Tüzün, H. Pazarli, S. Yurdakul, H. Ozyazgan, S. Ozdogan, et al.
Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome.
Ann Rheum Dis, 43 (1984), pp. 783-789
[82.]
I. Krause, Y. Uziel, D. Guedj, M. Mukamel, L. Harel, Y. Molad, et al.
Childhood Behcet's disease: clinical features and comparison with adult-onset disease.
Reumatology, 38 (1999), pp. 457-462
[83.]
Y. Bardak.
Effects of age and sex on Behçet's disease.
J Rheumatol, 26 (1999), pp. 1008-1009
[84.]
H. Demiroglu, S. Dundar.
Effects of age, sex, and initial presentation on the clinical course of Behçet's syndrome.
South Med J, 90 (1997), pp. 567
[85.]
D.S. Bang, S.H. Oh, K.H. Lee, E.S. Lee, S.N. Lee.
Influence of sex on patients with Behçet's disease in Korea.
J Korean Med Sci, 18 (2003), pp. 231-235
[86.]
E. Kural-Seyahi, I. Fresko, N. Seyahi, Y. Ozyazgan, C. Mat, V. Hamuryudan, et al.
The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center.
Medicine (Baltimore), 82 (2003), pp. 60-76
[87.]
P. Lin, G. Liang.
Behcet disease: Recommendation for clinical management of mucocutaneous lesions.
J Clin Rheumatol, 12 (2006), pp. 282-286
[88.]
L. Ravitskiy, J.J. Green, G. Goldenberg, J.L. Jorizzo.
Behcet's disease.
Treatment of skin disease comprehensive therapeutic strategies, 2ed., pp. 82-85
[89.]
E. Alpsoy, H. Er, C. Durusoy, E. Yilmaz.
The use of sucralfate suspension in the treatment of oral and genital ulceration of Behcet's disease.
Arch Dermatol, 135 (1999), pp. 529-532
[90.]
J.L. Jorizzo, R.D. Hudson, F.C. Schmalstieg, J.C. Daniels, P. Apisarnthanarax, J.C. Henry, et al.
Behçet's syndrome: immune regulation, circulating immune complexes, neutrophil migration, and colchicine therapy.
J Am Acad Dermatol, 10 (1984), pp. 205-214
[91.]
K. Sharquie, R. Najim, A. Abu-Raghif.
Dapsone in Behcet's disease: a double-blind, placebo-controlled, cross-over study.
J Dermatol, 29 (2002), pp. 267-279
[92.]
M.E. Chang, G.C. Liang.
Pentoxifylline use for Behcet's disease.
Arthritis Rheum, 43 (2000), pp. S363
[93.]
E.M. Chang, G.C. Liang.
Pentoxifylline use for Behcet's disease: a follow- up cohort study.
Arthritis Rheum, 44 (2001), pp. S120
[94.]
B. Goker, H. Goker.
Current therapy for Behcet's disease.
Am J Ther, 9 (2002), pp. 465-470
Copyright © 2009. Asociación Colombiana de Reumatología
